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Abstract  
Skin tumours are among the most frequent tumour types of mankind. In the case of large tumours, field 
cancerization, or satellitosis scalping surgery is a possible option. The procedure can also be used in a palliative 
setting with tumour debulking. Less common indications are multiple benign tumours of the scalp and chronic 
inflammatory scalp dermatoses not responding to medical treatment. We present a case series and discuss 
surgical modalities beyond curative surgery of primary skin cancer. 
 
 
 
 
Introduction 
 
The most common skin tumours are non-
melanoma skin cancers (NMSC). A very frequent 
localisation is the scalp. In the case of large tumours, 
a scalping surgery may become necessary. 
We define scalping surgery as full-thickness 
soft tissue removal of at least one-third of the 
capillitium resulting in large defects. Scalping surgery 
may also include removal of periosteum or outer table 
of the scalp. Large defects with full thickness loss of 
soft tissue down to the bone require complex 
reconstructive options. In many cases, complete 
defect closure can be obtained by local flaps, tissue 
expander or free vascularized flaps [1, 2]. 
Comorbidities among elderly patients often 
limit anaesthetic tolerance and the use of distant flaps. 
In such cases, a defect closure is performed by mesh 
graft transplantation. The graft take can be improved 
by a combination of a dermal matrix template. Such a 
technique allows also mesh graft transplantation on 
bony underground [3-7]. 
Since permanent alopecia is a consequence 
of scalping surgery, the procedure needs to be 
discussed with every single patient in detail. 
Nevertheless, scalping surgery has its place in 
primary tumour surgery, in cases of field cancerization 
of the scalp with multiple NMSC, palliative oncology, 
and in rare benign conditions. We will discuss the 
possible indications, outcome and limitations of such 
an aggressive surgical approach aside from curative 
surgery of primary skin tumours. 
 
 
Field cancerization 
 
A 76-year-old female patient presented in 
2011 with nevoid amelanotic melanoma and 
satellitosis of the scalp, which was BRAF-wild type. 
She was treated by Mohs surgery, and the defect was 
closed by a rotational flap. Since resection of 
satellitosis was incomplete, a second surgery was 
planned. But on return, she already presented multiple 
new non-pigmented cutaneous scalp metastases. We 
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started with intralesional interleukin-2 (IL-2) treatment 
in 2011 and performed five courses until 2014. Due to 
the new formation of scalp satellitosis, palliative laser 
therapy – initially by erbium-YAG, later by pulsed 
980nm diode laser – was performed as demanded. 
The treatment was better tolerated than IL-2 but no 
longer remission period could be achieved. More than 
100 metastases have been observed (Fig. 1).  
 
Figure 1: Satellitosis of multiple non-pigmented melanoma 
metastases 
 
Repeated imaging by X-ray, magnetic 
resonance imaging (MRI) and positron emission 
computerised tomography (PET) was negative for any 
metastatic spread distant from the scalp. Serum level 
of S100 remained low. Eventually, she was treated by 
scalping surgery followed by meshed skin graft 
transplantation. During follow-up of months, no 
relapse occurred (Fig. 2). 
 
Figure 2: After scalping surgery and meshed skin graft 
transplantation. The marked area was removed – it was a milia-like 
formation, no metastasis 
 
A 40-year-old male patients with cranial 
dysplasia, thoracic deformities, scoliosis, and a 
mandibular cyst was referred to us because of 
multiple basal cell carcinomas (BCCs) of the head 
measuring up to 4.5 cm in diameter. Some of the 
tumours were ulcerated (Fig. 3).  
 
Figure 3: Gorlin-Goltz syndrome with multiple basal cell carcinomas, 
some ulcerated 
 
Genetic analysis detected a heterozygous 
mutation c.290delA in exon 2 of the PTCH1 gene. Our 
findings confirmed the diagnosis of Gorlin-Goltz 
syndrome. The patient had been offered serial 
surgery, medical treatment with hedgehog inhibitor 
vismodegib, and scalping surgery. He decided to have 
scalping surgery which was performed under general 
anaesthesia (Fig. 4).  
 
Figure 4: After scalping surgery 
 
The full-thickness defect was closed in the 
second step by meshed skin graft transplantation (Fig. 
5). During follow-up of 10 months, there was no 
relapse. 
 
Figure 5: Five days after meshed skin graft transplantation 
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Debulking surgery  
 
We performed debulking surgery in an 80-
year-old male patient with a recurrent amelanotic 
lentigo melanoma of the scalp (Fig. 6).  
 
Figure 6: Relapsing Amelanotic lentigo maligna melanoma with 
penetration of the outer table of the scull 
 
The tabula externa was already infiltrated by 
this tumour. We removed the periosteal layer and 
used a diamond drill for perforating the outer cortical 
layer of the scull to improve blood supply (Fig. 7).  
 
Figure 7: Operation situs 
 
Sandwich transplantation with the elastin-
collagen dermal template and meshed skin graft in the 
same session provided a stable defect closure until 
neurosurgical complete tumour resection, and skull 
repair was possible (Fig. 8).  
 
 
Figure 8: Stable meshed skin graft ten days after surgery 
 
 
A 67-year-old male patient presented with a 
giant trichilemmal carcinoma of the scalp (20 x 12 x 
2.4 cm), Broder grade 3 (Fig. 9).  
 
Figure 9: Giant trichilemmal carcinoma of the scalp 
 
By cranial computerised tomography and 
gadolinium-enhanced vascular magnetic resonance 
imaging a parietal parasagittal cranial tumour invasion 
was detected (Fig. 10).  
 
Figure 10: MRI demonstrating penetration of the scull and 
impression of the sagittal sinus 
 
There was a continuous growth to the 
meninges on the left side with infiltration and partial 
closure of the medial part of the superior sagittal 
sinus. Together with the neurosurgeon, we decided to 
perform debulking surgery as a palliative treatment 
(Fig. 11).  
 
Figure 11: Operation situs 
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Overall survival from the first diagnosis was 
three years. He did not die from cancer but traffic 
accident one week before planned neurosurgery of 
the intracranial tumour residues. 
 
 
Chronic inflammatory scalp dermatoses 
 
30-year-old male patient with severe 
dissecting cellulitis of the scalp, who was treated in a 
neoadjuvant setting with anti-tumor necrosis factor-
alpha treatment compound infliximab, had been 
subjected to scalping surgery for treatment-resistant 
residues (Figs. 12 & 13).  
 
Figure 12: Dissecting folliculitis with severe inflammation and oozing 
lesions 
 
He is in complete remission now for more 
than five years without any medical treatment. 
 
Figure 13: Two years after scalping surgery with stable meshed skin 
transplant take. No relapse of dissecting folliculitis. 
 
 
Discussion 
 
Scalping surgery is a niche technique with 
several possible indications. The advantage of the 
technique is its radical removal of multiple lesions, the 
complete change of the local immunity and the 
easiness of follow-up. The major drawback is the 
permanent hair loss in the treated area. This is an 
important issue to be discussed in detail with every 
patient before surgery. 
Field cancerization is mostly used to describe 
the development of multiple actinic keratoses on the 
bald scalp. The (bald) scalp is an 
immunocompromised district according to the concept 
of Rucco [8]. In the case of only multiple superficial 
actinic keratoses, not responding to topical treatment, 
photodynamic therapy is a useful alternative [9]. 
We treated two patients with a related 
condition: A female patient with multiple cutaneous 
metastases of an amelanotic nevoid melanoma 
arising in a circumscribed area of her scalp without 
any metastasis to more distant sites and a male 
patient with Gorlin-Goltz syndrome (OMIM 109400) 
and multiple BCCs of the head [10]. 
Nevoid melanomas are melanomas that 
clinically and histologically resemble a nevus (only at 
low power magnification under the microscope), and 
can be divided into small cell and spitzoid types [11, 
12]. The patient we present developed satellitosis 
without metastatic spread to more distant sites. We 
observed that microscopic satellitosis does not 
necessarily translate into the lymphovascular 
infiltration of the tumour [13]. In one study, the 5-year 
overall and disease-free survivals in patients with 
microscopic satellitosis were 34% and 18%, 
respectively, demonstrating an unfortunate prognosis 
[14]. 
Our patient had multiple treatments for 
numerous non-pigmented cutaneous metastases, 
such as 2.94 µm erbium-YAG and 980 nm pulsed dye 
laser, low-dose interferon alfa, and intralesional 
interleukin 2 [15-17]. Objective complete remissions 
have been achieved by intralesional interleukin-2 in up 
to 69% [18]. None of these treatments yielded a 
longer remission in the present patient. Therefore, we 
discussed the opportunity of scalping surgery for the 
area of local cutaneous metastases. The patients 
agreed, and so far, we did not observe any 
recurrence. 
In Gorlin-Goltz syndrome, surgical excision 
allows removal BCCs with an overall chance of a cure 
between 94% to 98%. Surgical excision provides the 
advantage of three-dimensional margin control [19]. 
Recently, hedgehog inhibitor vismodegib was 
investigated for Gorlin-Goltz patients with 
unresectable or metastatic BCCs. In a pooled analysis 
of two vismodegib trials by Chang et al. (2016), 46 
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patients with Gorlin-Goltz syndrome were included. 
The investigator-rated best overall response reached 
31 to 81 % in patients with unresectable BCC (n = 33) 
and 50 % in patients with metastatic BCC (n = 6) [20]. 
On the other hand, there is increasing evidence for 
either primary or secondary tumour resistance to 
hedgehog inhibitors, the transformation of BCC to 
squamous cell carcinoma (SCC) and increased risk of 
development of cutaneous SCC after vismodegib 
therapy [21-23]. We observed no recurrence of BCCs 
after scalping surgery in the treated area. Before, 
newly developed BCCs were noted almost every 
month. 
In old patients, where other medical, surgical 
or radiological treatments and their combination is not 
tolerable anymore, a debulking surgery is a palliative 
approach to avoid tumour bleeding, secondary 
infection, diminish malodor and improve the quality of 
life of patients. Debulking surgery per se does not 
improve overall survival. However, in the case of 
possible combination with another non-surgical 
therapy, a positive effect on survival may be obtained. 
Liao et al. (2017) treated a 92-year-old male 
patients with a higher multinodular mass on the scalp 
by this technique. The diagnosis was a cutaneous B-
cell lymphoma of the parietooccipital region. Relapse-
free survival was six months, and overall survival was 
two years [24]. 
We performed debulking surgery in an 82-
year-old male patient with scull-penetrating 
amelanotic LMM and a 67-year-old male patient with 
scull-penetrating trichilemmal carcinoma [25]. Overall 
survival of the last patient was three years. The former 
patient was subjected to neurosurgical treatment. 
Sometimes, scalping surgery is an option in 
patients with multiple benign scalp tumours. Sebastian 
and his group treated a 63-year-old man by en-bloc 
resection of multiple cylindromas of the scalp. After 
excision and granulation-stimulating local therapy, the 
wound was covered with meshed skin grafts from the 
thighs, but widespread tension blisters with 
ulcerations were recalcitrant to topical treatment. The 
defects were eventually closed with EpiDex, a tissue-
engineered epidermal equivalent derived from outer 
root sheath keratinocytes [26]. 
Dissecting cellulitis of the scalp is a chronic 
inflammatory, oozing disorder with similarities to 
hidradenitis suppurative/ acne inverse. It can be 
recalcitrant to medical treatment. In such cases, 
scalping surgery with subsequent mesh graft 
transplantation is an option to improve patient’s quality 
of life [27]. 
In the case of exposed Calvary after scalping 
surgery, we employed two surgical techniques – either 
alone or in combination. Milling the exposed outer 
table of the scalp bone with a rose head burr driven by 
a pneumatic power drill exposes diploic veins in the 
cancellous bone. This increases survival of free 
transplants [28]. The use of a dermal template has 
been shown to increase skin graft survival and 
improve the mechanical quality of the transplant after 
healing [3-7]. We employed the sandwich technique 
with a reconstituted elastin-collagen matrix covered by 
meshed skin graft in a single operation [6]. 
Despite all advantages in medical treatments 
and laser technology, scalping surgery is an option in 
the management of skin cancer patients and severe 
chronic inflammatory disorders. 
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